Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2

Interventions

Tacrolimus 2Specimen Handling 2Lymphatic Irradiation 2Biopsy 2venetoclax 1selinexor 1olutasidenib 1fludarabine phosphate 1fludarabine 1decitabine and cedazuridine drug combination 1Thiotepa 1Sirolimus 1Receptors, Antigen, T-Cell 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Maintenance 1Levofloxacin 1Idarubicin 1Fibroblast Growth Factor 7 1Electrocardiography 1Cytarabine 1Clinical Laboratory Techniques 1Busulfan 1Bone Marrow Examination 1Blood Specimen Collection 1Azacitidine 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Myelodysplastic Syndromes × Lymphatic Irradiation × Clear all
NCT07582172 2026-05-12

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2 Not yet recruiting
35 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT06598969 2024-09-19

TMLI-MA

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Phase 2 Not yet recruiting
58 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡